<DOC>
	<DOCNO>NCT00017277</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy use high-energy x-rays damage tumor cell . Epoetin alfa may help prevent treat cancer-related anemia . It yet know whether radiation therapy effective without epoetin alfa treat head neck cancer . PURPOSE : Randomized phase III trial compare effectiveness radiation therapy without epoetin alfa treat patient head neck cancer .</brief_summary>
	<brief_title>Radiation Therapy With Without Epoetin Alfa Treating Patients With Head Neck Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Compare efficacy radiotherapy ( term local-regional control ) without epoetin alfa patient squamous cell carcinoma head neck . - Compare disease-specific overall survival patient treat regimen . - Compare hemoglobin level patient radiotherapy . - Compare acute late toxic effect regimens patient . OUTLINE : This randomize , double-blind , placebo-controlled , multicenter study . Patients stratify accord participate center , site disease ( larynx v hypopharynx v oropharynx vs oral cavity ) , T-classification ( T1-2 v T3-4 ) , N-classification intent systematic neck node dissection ( N0-1 v N2-3 without node dissection v N2-3 node dissection ) , hemoglobin level gender ( men 10-12.5 g/dL vs men 12.5-14 g/dL vs woman 10-12 g/dL vs woman 12-13.5 g/dL ) , type treatment ( EORTC standard vs vs randomized trial ) . Patients randomize 1 2 treatment arm . - Arm I : Patients undergo standard radiotherapy 5 day week receive concurrent epoetin alfa subcutaneously ( SC ) weekly . - Arm II : Patients undergo radiotherapy arm I receive concurrent placebo SC weekly . Treatment arm continue 6-8 week absence disease progression unacceptable toxicity . Patients follow 3-6 week 9-14 week , every 3 month 2 year , every 6 month 1 year , annually thereafter . After locoregional recurrence , patient follow every 6 month 1 year annually thereafter . PROJECTED ACCRUAL : A total 800 patient accrue study within 3 year .</detailed_description>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm squamous cell carcinoma oral cavity , larynx , oropharynx , hypopharynx Stage T1T4 , N No T1 , N0 glottic tumor No nodal disease unknown primary Previously untreated disease No distant metastasis Planned radiotherapy PATIENT CHARACTERISTICS : Age : 18 75 Performance status : WHO 02 Life expectancy : Not specify Hematopoietic : Hemoglobin great 10 g/dL great 14 g/dL men Hemoglobin great 10 g/dL great 13.5 g/dL woman Hepatic : Not specify Renal : Not specify Cardiovascular : No hypertension ( diastolic pressure great 100 mmHg ) refractory treatment No symptomatic cardiovascular disease No deep vein thrombosis Other : No malignancy except cure basal cell skin cancer carcinoma situ cervix No psychological , familial , sociological , geographical condition would preclude study compliance No smoking study Not pregnant nursing Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior neoadjuvant chemotherapy No concurrent chemotherapy Endocrine therapy : Not specify Radiotherapy : See Disease Characteristics No prior radiotherapy head neck area No concurrent nonconventional radiotherapy Surgery : No prior therapeutic surgery head neck area</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>stage I squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage II squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage III squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage IV squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage I squamous cell carcinoma oropharynx</keyword>
	<keyword>stage II squamous cell carcinoma oropharynx</keyword>
	<keyword>stage III squamous cell carcinoma oropharynx</keyword>
	<keyword>stage IV squamous cell carcinoma oropharynx</keyword>
	<keyword>stage I squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage II squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage III squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage I squamous cell carcinoma larynx</keyword>
	<keyword>stage II squamous cell carcinoma larynx</keyword>
	<keyword>stage III squamous cell carcinoma larynx</keyword>
	<keyword>stage IV squamous cell carcinoma larynx</keyword>
</DOC>